Across 16 first-hand reports, people mentioned a side effect 5 times (about 31 per 100 reports). The most common: nutrient depletion, myopathy related, fatigue. User reports show what people notice — they can't tell you whether Statins is safe for you.
“my LDL cholesterol was down to 100, a 50% improvement using 5mg and slightly better eating”
“I would also suggest avoiding statins, those are big pharma marketing garbage.”
Conclusion: These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.
Conclusion: Conclusion: This review further confirms that high-intensity statins reduce LDL by ≥50%, favoring rosuvastatin over atorvastatin. Additional data are needed to confirm the clinical significance on cardiovascular outcomes using real-world studies.
Conclusion: Ezetimibe or PCSK9 inhibitors may reduce non-fatal MI and stroke in adults at very high or high cardiovascular risk who are receiving maximally tolerated statin therapy or are statin-intolerant, but not in those with moderate and low cardiovascular risk.